Neuroblastoma treatment receives Orphan Drug Designation
Base to Base biotech podcast 30: Life sciences in Lithuania
Encouraging results from Canavan disease trial
Collaboration to address CAR-T cell therapy for brain cancer
New immunotherapy targets common cancer mutation
Synaffix and Qurient Therapeutics to develop dual-payload ADC
Tagomics publishes new approach to genome-wide epigenomic profiling
Fast-acting actin explains the survival of cancer cells
Phase 2 data for chronic inducible urticaria
Base to Base biotech podcast 28: CTPS1 and ocular therapeutics
Positive results from phase 1 Huntington’s disease trial
Potential for drug targeting BDCA2 and TACI